Expression of urokinase type plasminogen activator (u-PA) and U-PA inhibitor (PAI-1) in lung cancers: Clinical significance

被引：0
|
作者：
Brambilla, E [1 ]
Robert, C [1 ]
Bolon, I [1 ]
Decaussin, M [1 ]
机构：
[1] CHU Grenoble, Lung Canc Res Grp, Pathol Lab CJF 97 01, F-38043 Grenoble, France
来源：
LABORATORY INVESTIGATION | 1999年 / 79卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1066
引用
收藏
页码：181A / 181A
页数：1
相关论文
共 50 条
  • [1] CHARACTERIZATION OF THE BINDING OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) TO PLASMINOGEN, TO PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TO THE U-PA RECEPTOR
    LIJNEN, HR
    DECOCK, F
    COLLEN, D
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02): : 567 - 574
  • [2] Production of Urokinase-Type Plasminogen Activator (u-PA) and Plasminogen Activator Inhibitor-1 (PAI-1) in Human Brain Tumours
    Y. Arai
    T. Kubota
    T. Nakagawa
    M. Kabuto
    K. Sato
    H. Kobayashi
    Acta Neurochirurgica, 1998, 140 : 377 - 386
  • [3] Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours
    Arai, Y
    Kubota, T
    Nakagawa, T
    Kabuto, M
    Sato, K
    Kobayashi, H
    ACTA NEUROCHIRURGICA, 1998, 140 (04) : 377 - 386
  • [4] Significance of u-PA and PAI-1 expression on diseased glomeruli
    Hong, Yin-Feng
    Zhang, Zhi-Gang
    Zhang, Xiu-Rong
    Guo, Mu-Yi
    Fudan University Journal of Medical Sciences, 2001, 28 (01): : 17 - 20
  • [5] Lysophosphatidylcholine upregulates expressions of urokinase-type plasminogen activator (u-PA) and u-PA receptor in human macrophages
    Oka, H
    Kugiyama, K
    Ohta, Y
    Doi, H
    Ogata, N
    CIRCULATION, 1998, 98 (17) : 808 - 808
  • [6] Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma
    De Petro, G
    Tavian, D
    Copeta, A
    Portolani, N
    Giulini, SM
    Barlati, S
    CANCER RESEARCH, 1998, 58 (10) : 2234 - 2239
  • [7] Interleukin-1β regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells
    Chung, HW
    Wen, Y
    Ahn, JJ
    Moon, HS
    Polan, ML
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03): : 1332 - 1340
  • [8] MEASUREMENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND DERIVATIVES CONTAINING THE U-PA SERINE PROTEASE DOMAIN
    VANKEER, L
    DECLERCK, PJ
    VERSTREKEN, M
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1268 - 1268
  • [9] THE RELEASE OF PLASMINOGEN ACTIVATORS (T-PA AND U-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) AFTER VENOUS STASIS
    FALKON, L
    GARI, M
    BORRELL, M
    FONTCUBERTA, J
    BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (01) : 33 - 38
  • [10] Plasminogen activators (t-PA, u-PA) and plasminogen activator inhibitor (PAI-1) in synovial fluid from knee joint
    Rosc, D
    Powierza, W
    Zekanowska, E
    Zastawna, E
    Kotschy, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS600 - PS600
12345